DIFFUSE LARGE B-CELL LYMPHOMA GERMINAL CENTER B-CELL TYPE
Clinical trials for DIFFUSE LARGE B-CELL LYMPHOMA GERMINAL CENTER B-CELL TYPE explained in plain language.
Never miss a new study
Get alerted when new DIFFUSE LARGE B-CELL LYMPHOMA GERMINAL CENTER B-CELL TYPE trials appear
Sign up with your email to follow new studies for DIFFUSE LARGE B-CELL LYMPHOMA GERMINAL CENTER B-CELL TYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could an oral drug boost chemo for seniors with lymphoma?
Disease control OngoingThis study looks at whether adding an oral medication (CC-486, or oral azacitidine) to a standard reduced-dose chemo regimen (R-miniCHOP) can help people aged 75 and older with newly diagnosed aggressive B-cell lymphomas. The goal is to see if the combination improves how long pa…
Matched conditions: DIFFUSE LARGE B-CELL LYMPHOMA GERMINAL CENTER B-CELL TYPE
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
New combo therapy aims to boost immune attack on tough lymphomas
Disease control OngoingThis phase 2 trial tests whether adding varlilumab to nivolumab helps people with aggressive B-cell lymphomas that have returned or not responded to standard therapy. About 54 participants will receive either nivolumab alone or nivolumab plus varlilumab. The goal is to see if the…
Matched conditions: DIFFUSE LARGE B-CELL LYMPHOMA GERMINAL CENTER B-CELL TYPE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
Nanochip could spot lymphoma relapse early
Knowledge-focused OngoingThis study tests a new nanochip technology to see if it can better monitor how well treatment is working and detect if lymphoma comes back in people with diffuse large B-cell lymphoma. About 73 participants will provide blood samples during their standard chemotherapy. The goal i…
Matched conditions: DIFFUSE LARGE B-CELL LYMPHOMA GERMINAL CENTER B-CELL TYPE
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 11:36 UTC